Search results
Found 178 matches for
A new paper published in The Lancet Psychiatry sets out principles for responsibly testing innovative treatments for severe depression, based on treating more than 100 patients with approximately 1,000 infusions of ketamine over six years in Oxford.
Reshma Ramracheya
OCDEM Visitors and Affiliates
BSc (Hons), PhD Reshma Ramracheya - Visiting Scientist
Paul Johnson
OCDEM Principal Investigators
MA MD FRCS (Paed.Surg) FAAP Paul Johnson - Director of Oxford Islet Isolation and Islet Transplant Programmes and Professor of Paediatric Surgery
Charlotte Kelly
Administration OCDEM
BA (Hons), Asso. CIPD. Charlotte Kelly - Deputy Business Manager
Charlotte Pink
OCDEM Research Support
Charlotte Pink - Health Safety and Environmental Technician Apprentice
Leanne Hodson
OCDEM Principal Investigators
BSc (Hons), PhD Leanne Hodson - Professor of Metabolic Physiology
Sarah Howles
OCDEM Researchers
DPhil, MRCS (Eng), MA (Cantab) Sarah Howles - Academic Clinical Lecturer in Urology
Fredrik Karpe
OCDEM Principal Investigators
MD/PhD, FRCP Fredrik Karpe - Professor of Metabolic Medicine
Marie-Eve Piche
OCDEM Researchers
MD; PhD (Hons); FRCPC Marie-Eve Piche - Clinical Research Training Fellow
Patrik Rorsman
OCDEM Principal Investigators
BM, PhD, FRS, FMedSci Patrik Rorsman - Professor of Diabetic Medicine
Jeremy Tomlinson
DTU Associates OCDEM Principal Investigators
MB BCh, PhD, FRCP Jeremy Tomlinson - Professor of Metabolic Endocrinology